Exhibit 107
Calculation of Filing Fee Tables
424b5 (Form Type)
CytomX Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security Type | Security Title | Fee Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial effective date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | ||||||||||||
Newly Registered Securities | ||||||||||||||||||||||||
Fees to Be Paid | — | — | — | — | — | — | — | — | ||||||||||||||||
Fees Previously Paid | Equity | Common Stock | 457(o) | — | — | $250,000,000(1) | $109.10 per $1,000,000 | $27,275 | ||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||
Carry Forward Securities | — | — | — | — | — | — | — | — | — | |||||||||||||||
Total Offering Amounts | — | — | ||||||||||||||||||||||
Total Fees Previously Paid | $27,275 | |||||||||||||||||||||||
Total Fee Offsets | — | |||||||||||||||||||||||
Net Fee Due | — |
(1) Relates to the registration statement on Form S-3 (Registration No. 333-258510) filed by the Company for the sale of up to $250,000,000 of the Company’s securities, which was declared effective on August 18, 2021, pursuant to which the Company paid a registration fee of $27,275.